Redemption liability-driven net liabilities

Hong Kong IPO disclosure precedents · 42 companies, 42 items

Net current liabilities principally attributable to share redemption liabilities arising from Pre-IPO or special-rights investor instruments, typically accompanied by absence of committed bank credit facilities.

2023-12-29Prospectus
CONCORD HEALTHCARE GROUP CO., LTD.美中嘉和医学技术发展集团股份有限公司02453.HK

We recorded net current liabilities of RMB2,605.1 million and RMB3,433.9 million as of December 31, 2020 and 2021, respectively, primarily attributable to our redeemable capital contribution.

Summary · p. 13

Consequently, as of December 31, 2022, we recorded nil redeemable capital contribution, and we had significantly reduced our net current liabilities to RMB149.6 million and returned to a total equity position.

Summary · p. 13

Taking into consideration of financial resources presently available to us, our Directors are of the view, and the Joint Sponsors concur, that our working capital, which includes available cash and cash equivalents, anticipated cash flow from operations, bank loans and other borrowings, and net proceeds from the Global Offering, will be sufficient to meet our present requirements for the next 12 months from the date of this prospectus.

Summary · p. 14
The company's explanation, the adviser's view and the page in the filing: see Matters
2023-06-15Prospectus
YSB Inc.药师帮股份有限公司09885.HK

As of 31 December 2020, 2021 and 2022, we had net liabilities of RMB2,462.2 million, RMB2,908.5 million and RMB4,369.7 million, respectively.

Financial Information · p. 277

As of 31 December 2022, our total liquidity resources, including the bank balances and cash, time deposits, restricted bank deposits, and financial assets at fair value through profit and loss, amounted to RMB2.2 billion.

Summary · p. 7
The company's explanation, the adviser's view and the page in the filing: see Matters

Tell us